Why the study?
Does amlodipine provide antiatherosclerotic effects in patients with coronary artery disease?
Does amlodipine provide antiatherosclerotic effects in patients with coronary artery disease?
This review summarizes the evidence from major clinical trials regarding the antiatherosclerotic properties of amlodipine in patients with coronary artery disease.
Summarizes amlodipine trial evidence in CAD without quantification; leaves open precise effect-size assessment for guidelines.
Author discusses antiatherosclerotic effects of dihydropyridine calcium channel blocker, amlodipine, in patients with coronary artery disease. Results of randomized clinical trials PREVENT (2000), CAPARES (2000), CAMELOT (2004) and ENCORE II (2009) are analyzed.
No takes yet. Share an insight, caveat, or question.
Yu. M. Lopatin (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: